Awkward Trump Merkel meeting has little impact on markets
US markets closed the week on a slightly negative note, but all the action had already been absorbed with the Fed Reserve having made its rates decision. The meeting between President Donald Trump and German Chancellor Angela Merkel was a non-event in terms of financial markets.
Despite a mid-afternoon rally, the Dow finished in negative territory at 20,914 points, a fall of 0.1%. There was weakness amongst the financials with Goldman Sachs and JP Morgan falling more than 1%.
The NASDAQ marked time as it finished at 5901 points compared with the previous day’s close of 5900 points.
It was also a dour day for European markets as the FTSE 100 gained 0.1% to close at 7424 points.
However, this week’s G20 meeting of finance ministers and central bankers from the world’s largest economies which is being held in Germany could well be the catalyst for significant market moves. One of the key issues on the table will be the US’s stance on trade.
Ahead of this meeting there were only nominal upward movements in the DAX and the Paris CAC 40 as they gained 0.1% and 0.3% respectively.
Two of the more volatile commodities of the week, oil and gold were fairly static on Friday.
Oil finished the week just below US$49 per barrel and gold was nudging US$1230 per ounce after hitting US$1232 per ounce in mid-morning trading.
Base metals ended the week strongly with zinc and lead leading the way, both gaining more than 2%.
Zinc finished within a touch of its long-term high of just over US$1.30 per pound. Lead traded above US$1.03 per pound for the first time in March.
Nickel and copper were both up approximately 0.5%.
The Australian dollar is fetching US$0.77, having held on to most of the gains made post the Fed Reserve’s rate decision.
It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.